Safety of Abatacept in Rheumatoid Arthritis With Serologic Evidence of Past or Present Hepatitis B Virus Infection-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Safety of Abatacept in Rheumatoid Arthritis With Serologic Evidence of Past or Present Hepatitis B Virus Infection

Published:2016-05-26 Issue:6 Volume:68 Page:738-743
ISSN:2151-464X
Container-title:Arthritis Care & Research
language:en
Short-container-title:Arthritis Care & Research

Author:

Padovan Melissa¹,Filippini Matteo²,Tincani Angela²,Lanciano Elisabetta³,Bruschi Eleonora⁴,Epis Oscar⁴,Garau Pietro⁵,Mathieu Alessandro⁵,Celletti Eleonora⁶,Giani Leopoldo⁷,Tomietto Paola⁸,Atzeni Fabiola⁹,Sarzi Puttini Piercarlo⁹,Zuliani Francesca¹⁰,De Vita Salvatore¹⁰,Trotta Francesco¹,Grilli Anastasio¹,Puoti Massimo⁴,Govoni Marcello¹

Affiliation:

1. Università degli studi di Ferrara and Azienda Ospedaliero Universitaria S. Anna di FerraraFerrara Italy

2. Spedali Civili di BresciaBrescia Italy

3. Policlinico UniversitarioBari Italy

4. A. O. Ospedale Niguarda Cà GrandaMilano Italy

5. Policlinico Universitario MonserratoCagliari Italy

6. Università G. D'AnnunzioChieti‐Pescara Italy

7. Ospedale CivileLegnano Milano Italy

8. Azienda Ospedaliero‐Universitaria Ospedali Riuniti di TriesteTrieste Italy

9. Ospedale SaccoMilano Italy

10. Università degli studi di UdineUdine Italy

Publisher

Wiley

Subject

Rheumatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/acr.22786

Reference44 articles.

1. World Health Organization. Hepatitis B fact sheet 2014. URL:http://www.who.int/mediacentre/factsheets/fs204/en/index.html.

2. Safety of TNF-blocking agents in rheumatic patients with serology suggesting past hepatitis B state: results from a cohort of 21 patients

3. Safety of tumor necrosis factor α blockers in hepatitis B virus occult carriers (hepatitis B surface antigen negative/anti-hepatitis B core antigen positive) with rheumatic diseases

4. Hepatitis B Virus (HBV) Reactivation in Patients Receiving Tumor Necrosis Factor (TNF)-Targeted Therapy

5. Prevalence of reactivation of hepatitis B virus replication in rheumatoid arthritis patients

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. What is the benefit of prophylaxis to prevent HBV reactivation in HBsAg‐negative anti‐HBc‐positive patients? Meta‐analysis and decision curve analysis;Liver International;2024-08-29

2. Entzündlich-rheumatische Erkrankungen im Kontext von HIV, Hepatitis B und C;Aktuelle Rheumatologie;2024-04

3. Recomendaciones SER sobre la gestión de riesgo del tratamiento con FAME biológicos o sintéticos dirigidos en pacientes con artritis reumatoide;Reumatología Clínica;2023-12

4. Recommendations by the Spanish Society of Rheumatology on risk management of biological treatment and JAK inhibitors in patients with rheumatoid arthritis;Reumatología Clínica (English Edition);2023-12

5. HBV reactivation in HBsAg−/HBcAb+ rheumatoid arthritis patients receiving biologic/targeted synthetic DMARDs;Liver International;2023-11-27

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3